Filed: 4/13/2023ACC: 0000950123-23-003235
π What this filing means
VIDA VENTURES ADVISORS, LLC filed this quarterly 13FβHR report disclosing 7 equity positions with a total reported market value of $73.09M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
7
Positions
$73.09M
Total AUM (reported)
16.67M
Total Shares
Allocation by class
COMMON STOCK$53.48M73.2%
ORDINARY SHARES$19.61M26.8%
Portfolio Concentration
Top 3$54.51M74.6%
4β10$18.58M25.4%
Top 3 weight
74.6%
Top 10 weight
100.0%
Voting Authority Distribution
Total shares with voting rights: 16.67M
Sole
Full voting authority
16.67M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole7
Shared0
Other0
Dominant voting typeSole Β· 100.0% of voting shares
Institutional Holdings7
Rows:
Dyne Therapeutics, Inc.
SOLEShares2.22M
TypeSH
Market value$25.57M
34.99%
Sole
2.22M
Shared
0.00
None
0.00
Centessa Pharmaceuticals plc
SOLEShares3.93M
TypeSH
Market value$15.14M
20.71%
Sole
3.93M
Shared
0.00
None
0.00
Kinnate Biopharma, Inc.
SOLEShares2.21M
TypeSH
Market value$13.80M
18.88%
Sole
2.21M
Shared
0.00
None
0.00
Allogene Therapeutics, Inc.
SOLEShares1.80M
TypeSH
Market value$8.88M
12.15%
Sole
1.80M
Shared
0.00
None
0.00
LianBio
SOLEShares2.28M
TypeSH
Market value$4.47M
6.12%
Sole
2.28M
Shared
0.00
None
0.00
Kronos Bio, Inc.
SOLEShares2.77M
TypeSH
Market value$4.04M
5.52%
Sole
2.77M
Shared
0.00
None
0.00
Praxis Precision Medicines, Inc.
SOLEShares1.47M
TypeSH
Market value$1.19M
1.63%
Sole
1.47M
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting β Sole | Shared | None |
|---|---|---|---|---|---|---|---|
Dyne Therapeutics, Inc.SOLE | Common Stock | 2.22M | SH | $25.57M 34.99% | 2.22M | 0.00 | 0.00 |
Centessa Pharmaceuticals plcSOLE | Ordinary Shares | 3.93M | SH | $15.14M 20.71% | 3.93M | 0.00 | 0.00 |
Kinnate Biopharma, Inc.SOLE | Common Stock | 2.21M | SH | $13.80M 18.88% | 2.21M | 0.00 | 0.00 |
Allogene Therapeutics, Inc.SOLE | Common Stock | 1.80M | SH | $8.88M 12.15% | 1.80M | 0.00 | 0.00 |
LianBioSOLE | Ordinary Shares | 2.28M | SH | $4.47M 6.12% | 2.28M | 0.00 | 0.00 |
Kronos Bio, Inc.SOLE | Common Stock | 2.77M | SH | $4.04M 5.52% | 2.77M | 0.00 | 0.00 |
Praxis Precision Medicines, Inc.SOLE | Common Stock | 1.47M | SH | $1.19M 1.63% | 1.47M | 0.00 | 0.00 |